Showing results (121-130 of 295) with videos related to
Sort By:
Pageof 30
Lipids|June 1, 1996
Diversity of the polar lipids of the food-borne pathogen Listeria monocytogenesS K Mastronicolis, J B German, G M SmithThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Identification of an orally active, nonpeptidyl oxytocin antagonistD J Pettibone, B V Clineschmidt, M T Kishel, et al.Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.Journal of Medicinal Chemistry|October 16, 1992
Orally active, nonpeptide oxytocin antagonistsB E Evans, J L Leighton, K E Rittle, et al.Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.Pageof 30